Biggest News Aggregation in the World
๐Ÿ“ฐ Action Date News

Page 3 - Action Date News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Action Date. Real-time updates on events, politics, business and more.

FDA Accepts BioMarin's Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Adults with Severe Hemophilia A

If Approved, Would Be 1st Gene Therapy in U.S. for Treatment of Severe Hemophilia A PDUFA Target Action Date is March 31, 2023 SAN RAFAEL, Calif., Oct. 12, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the U.S. Fo...
United States Hank Fuchs Debra Charlesworth Traci Mccarty European Commission Drug Administration

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001
Switzerland General Michael Miller Jack Weinstein Advita Lifescience Gmb Relief Therapeutics Holding Sa Key Pharma Research

Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the P

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval08-Jun-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the...
Michael Miller Jack Weinstein Advita Lifescience Gmb Relief Therapeutics Holding Sa Key Pharma Research Drug Administration

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

FDA Accepts Alkermes' Resubmission of New Drug Application for ALKS 3831

FDA Accepts Alkermes Resubmission of New Drug Application for ALKS 3831 - FDA Sets PDUFA Target Action Date of June 1, 2021 - DUBLIN, Dec. 29, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the companys New Drug Application (NDA) resubmission for ALKS 3831 (olanzapine/samidorphan) for the treatment of adults with schizophrenia and adults with bipolar I disorder, and has assigned the application a new ...
United States Marisa Borgasano Sandy Coombs American Psychiatric Association National Institutes Of Health Drug Administration

TCM0078620 - Tax Credits Manual - HMRC internal manual

If itโ€™s a single claim by one customer, go to Step 6. If itโ€™s a joint claim by two customers, go to Step 8. Step 6 Use Function MANAGE VERIFICATION FAILURES to check which residency rules the customer has failed verification on. To do this select the record you want to investigate select [Investigate]. You will be taken to the Investigate Verification Failure screen check which residency rules the customer has failed verification on Note: Check Household Notes to check if the claim has alre...
United Kingdom International Team Management Unit Data Guardian Or Security Team Data Guardian Security Team Team Or International International Team
Source: gov.uk

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science